Tirzepatide: Zepbound, Costs, Coverage, and Provider Guides

Tirzepatide is the active ingredient in Zepbound and Mounjaro. Product-specific indications and coverage matter: a diabetes medicine and a weight-management prescription are not the same insurance question. Use this guide to find the evidence, cost, and access information relevant to your situation.

Understand the treatment being offered

Zepbound is FDA-approved for weight management in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity. Its prescribing information gives the dosing and safety requirements.¹ Read eligibility and the sleep-apnea guide before interpreting a provider's screening form as an approval.

Compounded tirzepatide is a different finished product with a different regulatory status. FDA does not approve compounded drugs, and the conditions for lawful compounding still apply.² Our compounding-status guide covers both semaglutide and tirzepatide rules.

Find the answer you need

Coverage and cost deserve separate checks

Read insurance coverage to understand the difference between a covered benefit and an approved authorization. Savings-card rules explain commercial offers; Medicare's GLP-1 Bridge has its own criteria and eligible device.

Before choosing a service, request the expected maintenance-dose charge, actual billing interval, and every separate care fee. A four-week supply and a calendar-month subscription are not the same unit. The cost calculator helps compare recorded plan commitments, while the pharmacy must confirm the actual medication bill.

Compare the care behind the prescription

Ro and Form Health describe different approaches to prescribing and support. Ondra Health gives another service comparison. Ask how each handles side effects, interruptions, prior authorization, and follow-up before paying.

The tirzepatide board contains a broader inventory, including compounded services. A position on the board is not a determination that a particular compounded prescription meets legal conditions, and a brand-access flag is not guaranteed availability for every patient.